Peer Review History
| Original SubmissionAugust 28, 2025 |
|---|
|
Dear Dr. Amoako, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Saki Raheem, PhD Academic Editor PLOS ONE Journal requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. We note that you have referenced “Abigail Agbanyo, Michael Ntiamoah Oppong, Dzifa Kofi Ahiatrogah, Ruth Dede Tuwor, Clement Tettey, Joseph Azabire, et al. and Abigail Agbanyo, Michael Ntiamoah Oppong, Ruth Dede Tuwor, Shadrach Mintah, Victor Yaw Morgan, Clement Tettey, et al.” which has currently not yet been accepted for publication. Please remove this from your References and amend this to state in the body of your manuscript: (Abigail Agbanyo, Michael Ntiamoah Oppong, Dzifa Kofi Ahiatrogah, Ruth Dede Tuwor, Clement Tettey, Joseph Azabire, et al. and Abigail Agbanyo, Michael Ntiamoah Oppong, Ruth Dede Tuwor, Shadrach Mintah, Victor Yaw Morgan, Clement Tettey, et al. [Submitted ]) as detailed online in our guide for authors-->-->http://journals.plos.org/plosone/s/submission-guidelines#loc-reference-style-->--> -->-->3. Please upload a new copy of Figures 1 to 4 as the detail is not clear. Please follow the link for more information: https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/-->--> -->-->4. We note that there is identifying data in the Supporting Information file. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws.-->--> -->-->Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared:-->--> -->-->-Name, initials, physical address-->-->-Ages more specific than whole numbers-->-->-Internet protocol (IP) address-->-->-Specific dates (birth dates, death dates, examination dates, etc.)-->-->-Contact information such as phone number or email address-->-->-Location data-->-->-ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order)-->--> -->-->Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants.-->--> -->-->Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long.-->--> -->-->Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.-->--> -->-->5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.-->?> [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The manuscript “Dietary variability and micronutrient status of individuals with Yaws infection in Ghana: a case-control study” by Abigail Agbanyo et al. aims to reveal possible connections between nutritional status of individuals and yaws disease. This manuscript is well written and the topic is very interesting, but I have several concerns: - Study setting: o What was the reasoning behind selection of the studied communities and districts? Were they selected only because of consistent reports of yaws cases in the recent years, or were there other factors considered? Are these the only areas where cases of yaws are reported? I would appreciate more details and maybe a map of Ghana with the studied areas marked, as well as all the regions with yaws cases present. - Study design: o The participants were recruited over the period of seven months. Could the different times of the year have an influence on the nutrient intake? Discussion briefly mentions the seasonality of fruits and vegetables, does the season also affect availability of other food groups? - Data analysis: o Was any correction for multiple testing applied to the statistical tests used in the study? - Results: o In demographic characteristics description on lines 219 and 220, specify what is compared. It states that the sex distribution was not statistically significant, but the first part of the sentence mentions only 74% of males versus 26% females, which would be statistically significant difference. o For the analysis of anthropometric characteristics, what data was used for the calculations? Baseline? Follow up? Both? Throughout the results, this information is stated only in some places. Please make this clear in both Methods and Results. o Results are not divided by sex. It would be interesting to see such analysis as it would provide more details on how the nutrient intake differs between both sexes and if the nutrient intake inadequacy is more common in males or females. I only see the sex factor taken into account in the Adequacy of nutrient intake part of the Results, but not in the general analysis of the Nutrient intake and diversity. Is there a reason why this was not done? o Figure 4 shows p-values, but which categories (clinical forms) were compared? The Dunn’s post-hoc test should identify which comparisons were statistically significant. Do the values shown always represent the comparison between Ulcers and Papillomas, as is currently marked in the Figure? Please add more details in the text. - Discussion o In general, the Discussion could be shorter. While the connections between different diseases and the stunting rates found in other studies and the possible effect of disease on nutrient intake or vice versa are very interesting, I would try to make this more concise. Minor comments: - Check the numbering of references. The citation on line 116 is numbered out of order. - Line 163 and 166: Incorrect term. Sex should be used instead of gender. - Text on Figures is too small and almost unreadable. Reviewer #2: This is a nice negative study demonstrating that nutrition seems to have little/no role in yaws but that under-nutrition is commonly found in yaws endemic communities. Major Comments: The methods are fairly well describe but there isnt a sample size section - was this calculated or was the sample size based on convenience of matching cases found in the previous study to controls? If there was a sample size calculation if should be included. Please give a bit more detail on the matching of controls. For example I would have considered a similar age/gender might be important or potentially selecting someone without yaws but within the same household which would provide additional control for variations in exposure. I would be more cautious in saying there are micronutrient differences - as the authors note the differences are not statistically significant and even if they were I dont think these are clinically significant differences i.e a <1% difference in Vitamin C intake etc. There is a lot of testing (i,e if each micronutrient is associated with lesion type) - this is at least 13 comparisons; I would consider adjusting for multiple comparisons which i suspect would make even the weak associations detected become non-significant. (Similar point for table 7) I suspect the discussion could be tigheter and shorter given the essentially null findings. Minor Comments: Drug names like Azithromycin dont need to be capitalised. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Dietary variability and micronutrient status of individuals with Yaws infection in Ghana: a case-control study PONE-D-25-45732R1 Dear Dr. Amoako, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Saki Raheem, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: (No Response) ********** Reviewer #2: I am satisfied the authors have responded to the comments adn the paper can be accepted for publication. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-45732R1 PLOS ONE Dear Dr. Amoako, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Saki Raheem Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .